The present invention relates to a treatment agent for a disease or a disorder caused by a reduction in corneal endothelial cells, comprising as an active component at least one nucleic acid molecule inhibiting the expression of a connexin 43 gene.

 
Web www.patentalert.com

< RIBOZYME MEDIATED STABILIZATION OF POLYNUCLEOTIDES

> METHOD FOR INCREASING THE SALTWATER TOLERANCE OF A FISH

> ANTHELMINTIC AND/OR INSECTICIDE DEVELOPMENT

~ 00528